精神分裂症与新发炎症性肠病风险:一项全国性纵向研究
该回顾性人群队列研究利用台湾全民健康保险研究数据库2001年1月1日至2011年12月31日数据,纳入116 164例精神分裂症患者与464 656例匹配对照(1:4匹配),发现患者新发炎症性肠病风险显著升高(HR 3.28,95%CI 2.49-4.33),且精神科住院每年超过一次者风险更高(HR 7.99,95%CI 5.25-12.15)。
要点
- 精神分裂症患者新发炎症性肠病风险显著高于匹配对照(HR 3.28,95%CI 2.49-4.33)。
- 精神分裂症患者炎症性肠病平均诊断年龄46.82岁,对照为55.30岁。
- 每年精神科住院超过一次者炎症性肠病风险HR 7.99(95%CI 5.25-12.15),高于住院较少者的HR 2.72(95%CI 2.03-3.66)。
核心结论
- 该人群队列研究显示精神分裂症与后续炎症性肠病发生存在显著关联。
- 精神分裂症患者炎症性肠病发病年龄更轻,且风险随精神分裂症控制不佳而升高。
- 作者认为医生提高对该关联的警惕和认识将改善这一脆弱患者人群的炎症性肠病诊断与管理。
研究设计与样本
- 回顾性人群队列研究,利用台湾全民健康保险研究数据库2001年1月1日至2011年12月31日收集的患者数据。
- 纳入由委员会认证精神科医生诊断精神分裂症且既往无炎症性肠病诊断的患者,按年龄、性别、居住地、收入水平和医学合并症以1:4匹配对照。
- 采用Cox回归分析计算新发炎症性肠病的校正风险比(HR)并进行亚组分析。
- 样本包括116 164例精神分裂症患者和464 656例匹配对照。
主要发现
- 精神分裂症患者炎症性肠病总体发生率为1.14%,匹配对照为0.25%。
- 精神分裂症患者炎症性肠病平均诊断年龄为46.82岁,对照为55.30岁。
- 精神分裂症患者发生炎症性肠病的HR为3.28(95%CI 2.49-4.33)。
- 每年精神科住院超过一次者炎症性肠病风险HR为7.99(95%CI 5.25-12.15),住院较少者HR为2.72(95%CI 2.03-3.66)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) is a chronic gastrointestinal inflammatory disorder with increasing global prevalence. The risk of IBD in patients with schizophrenia remains unclear. We aim to investigate the risk of new-onset IBD in patients with schizophrenia compared with matched controls. METHODS: We conducted a retrospective, population-based cohort study utilising patient data from the Taiwan National Health Insurance Research Database collected between January 1, 2001, and December 31, 2011. Patients diagnosed with schizophrenia by board-certified psychiatrists without prior diagnosis of IBD were enrolled and matched to controls in 1:4 fashion by age, sex, residence, income level and medical comorbidities. Adjusted hazard ratios (HRs) for new-onset IBD and sub-analyses were determined using Cox regression analysis with adjustments. RESULTS: Among 116 164 patients with schizophrenia and 464 656 matched controls, overall incidence of IBD among patients was significantly higher (1.14% vs. 0.25%). Average age of IBD diagnosis was 46.82 among patients with schizophrenia, versus 55.30 among controls. The HR of developing IBD among patients was 3.28, with a 95% confidence interval (95% CI) 2.49-4.33. IBD risk was higher among patients with psychiatric admissions more than once per year (HR 7.99, 95% CI 5.25-12.15) compared to those hospitalised less frequently (HR 2.72, 95% CI 2.03-3.66). CONCLUSIONS: This population-based cohort study demonstrates a significant association between schizophrenia and subsequent IBD development. Patients with schizophrenia develop IBD at a younger age, and the risk increases with inadequately controlled schizophrenia. Physician vigilance and awareness of this correlation will improve IBD diagnosis and management among this vulnerable patient population.
引用
- Sung KY, Zhang B, Wang HE, et al. Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study. Aliment Pharmacol Ther. 2022. PMID: 35261051. doi:10.1111/apt.16856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。